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PREP (Prediction of risks in early onset pre-eclampsia) is
a multicentre prospective cohort study aiming to develop
and validate a prediction model in women admitted with
early-onset pre-eclampsia for risk of adverse maternal
outcome at 48 hours and until discharge. The primary
outcome was a composite of adverse maternal outcomes
and the secondary outcome a composite of adverse fetal
outcomes.
The planned model includes multiple predictor variables
in combination to predict the risk of adverse outcomes in
individual patients. We highlight the methodological chal-
lenges encountered in model development.
The predictor variables were pre-selected based on
symptoms, signs and results of investigations routinely
taken during management of pre-eclampsia. Challenges
included accounting for correlation between variables,
choosing the most abnormal variable within a time period
or from a pre-determined time point, inconsistency in
ascertainment of the data points ie blood results available
later than the signs and symptoms, modelling a combina-
tion of binary, ordinal and continuous variables and the
approach in prioritisation of these variables.
Clinician management such as anti-hypertensives and
magnesium sulphate will affect the relationship between
the predictor and outcome. We will include clinical man-
agement as a covariate and assess consistency in model
performance across different treatment groups to account
for this.
Selecting the optimum type of prediction model posed
a further challenge. Logistic regression focuses on the
relationship between predictor variables and adverse
outcomes whereas survival analysis takes into account
the time to develop the outcome. The former may be
statistically more suitable but the latter clinically more
useful.
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